BLUEJET.NS Blue Jet Healthcare Ltd.
Price history
Price is the daily close from stored Kite history. The other metrics pair that daily price with the company's periodic filings — each fundamental (revenue, EPS, equity…) is held flat at its latest filed value between annual filings, so a ratio steps at each filing and moves daily only through its price term. A metric with no input on file for this company (e.g. EV/EBITDA for a bank, which has no EBIT) is shown as unavailable, never guessed. Share-count-based metrics use the latest diluted share count against split/bonus-adjusted prices.
Technical indicators
ℹ These reflect only the stock's recent price and volume behavior — not the company's fundamentals — and are not a recommendation to buy or sell. Standard published parameters are used throughout (see each chart's own label); a company with too little stored price history for a given indicator's lookback window shows that plainly below rather than a garbage or misleading value.
MACD (12,26,9), Stochastic Oscillator (14,3) and Money Flow Index (14-day) each carry their own published reference lines/bands (20/80 for the oscillator readings) where one is standard. ADX includes +DI/-DI for direction alongside trend strength; a dashed line marks the commonly published 25 "trending market" reading. ATR is shown in raw rupees here; the price/volume preset screen (below, and on the Screener page) reports it as a % of price so it's comparable across stocks at different price levels. Computed from the same stored daily OHLCV history as the price chart above — no new data source.
Delivery volume
| Date | Traded Qty | Delivery Qty | Delivery % |
|---|---|---|---|
| 2026-08-28 | 378817 | 220023 | 58.08% |
| 2026-08-27 | 250159 | 142682 | 57.04% |
| 2026-08-26 | 304935 | 155599 | 51.03% |
| 2026-08-25 | 314126 | 157777 | 50.23% |
| 2026-08-24 | 1443893 | 454825 | 31.50% |
| 2026-08-21 | 397216 | 194152 | 48.88% |
| 2026-08-20 | 370165 | 194457 | 52.53% |
| 2026-08-19 | 449751 | 243767 | 54.20% |
| 2026-08-18 | 1660898 | 898592 | 54.10% |
| 2026-08-17 | 340303 | 185533 | 54.52% |
| 2026-08-14 | 571595 | 315725 | 55.24% |
| 2026-08-13 | 740357 | 393498 | 53.15% |
| 2026-08-12 | 312902 | 147400 | 47.11% |
| 2026-08-11 | 451052 | 242613 | 53.79% |
| 2026-08-10 | 521729 | 295207 | 56.58% |
| 2026-08-07 | 517530 | 233612 | 45.14% |
| 2026-08-06 | 1676997 | 615798 | 36.72% |
| 2026-08-05 | 1550452 | 741233 | 47.81% |
| 2026-08-04 | 1572783 | 572175 | 36.38% |
| 2026-08-03 | 6512064 | 1812000 | 27.83% |
Delivery quantity/percentage from the NSE bhavcopy (DELIV_QTY/DELIV_PER) — the share of that day's traded volume that actually settled into a demat account, rather than being squared off intraday. A higher delivery percentage is commonly read as genuine accumulation/distribution rather than speculative same-day trading; this describes recent trading PATTERN, not the company itself, and is not a recommendation to buy or sell. A blank cell is a day NSE itself published no figure for, never a zero. Run python manage.py refresh_delivery_volumes --tickers BLUEJET.NS to fetch more history.
Insider trading activity
No insider-trading disclosures on file — run python manage.py refresh_insider_trades --tickers BLUEJET.NS. (No stored disclosures may mean none have been fetched yet, or that NSE has genuinely published none for this company.)
Extract this company (financials + ratios + citations): CSV · XLSX
Full statements: Profit & Loss · Balance Sheet · Cash Flow · Compare with 46 peers in Healthcare · Trace Score
Ratios
This is cash paid during the fiscal year, not a per-share rate declared for it (no such element exists in the filing data) — timing can straddle interim/final dividends across years, and pre-FY2020-21 figures may include the since-abolished Dividend Distribution Tax, reading higher than later years for that reason alone.
Growth & earnings trend
Revenue & Profit CAGR
Operating Margin Trend
ROCE Trajectory
Earnings Quality
Needs net profit and CFO for 3+ stored years; only 0 on file.
Sector-Relative Percentile (Healthcare)
Quarterly trend
| Metric (to shareholders basis) | Q4 FY2023-24 | Q1 FY2024-25 | Q2 FY2024-25 | Q3 FY2024-25 | Q4 FY2024-25 | Q1 FY2025-26 | Q2 FY2025-26 | Q3 FY2025-26 | Q4 FY2025-26 | Q1 FY2026-27 | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹183.94 Cr. | ₹162.90 Cr. | ₹208.26 Cr. | ₹318.38 Cr. | ₹340.44 Cr. | ₹354.76 Cr. | ₹165.48 Cr. | ₹192.41 Cr. | ₹234.67 Cr. | ₹293.11 Cr. | RevenueFromOperations |
| Net Profit | ₹39.49 Cr. | ₹37.78 Cr. | ₹58.35 Cr. | ₹98.98 Cr. | ₹110.09 Cr. | ₹91.17 Cr. | ₹52.14 Cr. | ₹40.17 Cr. | ₹64.34 Cr. | ₹78.26 Cr. | ProfitLossForPeriod |
Primary figures are Revenue from Operations and Net Profit attributable to shareholders — the basis the ratios use. Where they differ, the companion Gross revenue (incl. inter-segment) and incl. minority net profit (the totals a news headline usually quotes) are shown beneath, each traceable to its own XBRL element. Quarters shown are however many are actually stored (up to 10) — run python manage.py refresh_quarterly_trend --tickers BLUEJET.NS to fetch more.
Source document — income statement (FY2025-26, raw filing line items)
View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.
| ProfitLossForPeriod | 2478160000.0 |
| PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital | 173465000.0 |
Source document — balance sheet (FY2025-26, raw filing line items)
View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.
| CurrentAssets | 9570430000.0 |
| CurrentLiabilities | 2274560000.0 |
| EquityAttributableToOwnersOfParent | 13599120000.0 |
| BorrowingsCurrent + BorrowingsNoncurrent | — |